These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15449303)

  • 21. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine enhances autonomy in moderate to severe Alzheimer's disease.
    Rive B; Vercelletto M; Damier FD; Cochran J; François C
    Int J Geriatr Psychiatry; 2004 May; 19(5):458-64. PubMed ID: 15156547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD.
    Hellweg R; Wirth Y; Janetzky W; Hartmann S
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):651-6. PubMed ID: 22513699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-dementia therapy pays at every stage of the disease. Patients with Alzheimer's disease stay all-day fit longer].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():113. PubMed ID: 14579507
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of the effects of memantine on clinical progression in Alzheimer's disease.
    Wilkinson D
    Int J Geriatr Psychiatry; 2012 Aug; 27(8):769-76. PubMed ID: 21964871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy of dementia in elderly patients. A review.
    Olsen CE; Poulsen HD; Lublin HK
    Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)].
    Agüera-Ortiz LF;
    Rev Neurol; 2010 Nov; 51(9):525-34. PubMed ID: 20979032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of memantine to treat Alzheimer's disease.
    Gauthier S; Herrmann N; Ferreri F; Agbokou C
    CMAJ; 2006 Aug; 175(5):501-2. PubMed ID: 16940271
    [No Abstract]   [Full Text] [Related]  

  • 33. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003154. PubMed ID: 15846650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].
    Schmidt R; Baumhackl U; Berek K; Brücke T; Kapeller P; Lechner A; Rainer M; Stögerer EM
    Neuropsychiatr; 2010; 24(2):125-31. PubMed ID: 20605008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003154. PubMed ID: 16034889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memantine for dementia.
    McShane R; Areosa Sastre A; Minakaran N
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003154. PubMed ID: 16625572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alzheimer dementia. Memantine: value for patient and caregivers].
    MMW Fortschr Med; 2009 Nov; 151(45):44-5. PubMed ID: 19960725
    [No Abstract]   [Full Text] [Related]  

  • 39. Memantine for Alzheimer's disease.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):73-4. PubMed ID: 12968123
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
    Ballard C; Corbett A; Chitramohan R; Aarsland D
    Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.